Assessment of nociceptin/orphanin FQ and -opioid receptor mRNA in the human right atrium

British Journal of Anaesthesia

Volumn 104, Issue 6, 2010, Pages 698-704

  McDonald, J ^a   Leonard, A D ^a   Serrano Gomez, A ^a   Young, S P ^a   Swanevelder, J ^b   Thompson, J P ^a   Lambert, D G ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Heart, heart failure; Polymerase chain reaction; Receptors, mu opioid; Receptors, nociceptin orphanin FQ

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEPARIN; ISOFLURANE; MESSENGER RNA; MU OPIATE RECEPTOR; NOCICEPTIN; PANCURONIUM;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART RIGHT ATRIUM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 77952538785     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeq089     Document Type: Article

References (32)

1. McDonald J, Lambert DG. Opioid receptors. Contin Educ Anaesth Crit Care Pain 2005;5:22-5
2. Lambert DG. The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nat Rev Drug Discov 2008;7:694-710
3. Dietis N, Guerrini R, Calo G, Salvadori S, Rowbotham DJ, Lambert DG. Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. Br J Anaesth 2009;103:38-49
4. Molina PE. Opioids and opiates: analgesia with cardiovascular, haemodynamic and immune implications in critical illness. J Intern Med 2006;259:138-54
5. Bodnar RJ. Endogenous opiates and behavior: 2007. Peptides 2008;29:2292-375
6. Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician 2008;11: S105-20
7. Zaugg M, Lucchinetti E, Uecker M, Pasch T, Schaub MC. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. Br J Anaesth 2003;91:551-65
8. Zaugg M, Lucchinetti E, Garcia C, Pasch T, Spahn DR, Schaub MC. Anaesthetics and cardiac preconditioning. Part II. Clinical implications. Br J Anaesth 2003;91:566-76 (Pubitemid 37258601)
9. Ela C, Barg J, Vogel Z, Hasin Y, Eilam Y. Distinct components of morphine effects on cardiac myocytes are mediated by the kappa and delta opioid receptors. J Mol Cell Cardiol 1997;29:711-20
10. Barron BA. Cardiac opioids. Proc Soc Exp Biol Med 2000;224:1-7
11. 3H]nociceptin binding site in membrane preparations of rat heart: correlations with the non-opioid dynorphin binding site. J Mol Cell Cardiol 1998;30:2751-60
12. Berger H, Albrecht E, Wallukat G, Bienert M. Antagonism by acetyl-RYYRIK-NH2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ. Br J Pharmacol 1999;126:555-8
13. Kim KW, Chung YJ, Han JH, et al. Nociceptin/orphanin FQ increases ANP secretion in neonatal cardiac myocytes. Life Sci 2002;70:1065-74
14. Leonard AD, Thompson JP, Hutchinson EL, et al. Urotensin II receptor expression in human right atrium and aorta: effects of ischaemic heart disease. Br J Anaesth 2009;102:477-84
15. Campbell DJ, Rowbotham DJ, Lambert DG. Do nitrous oxide and halothane influence opioid receptor binding in SH-SY5Y human neuroblastoma cells? Br J Anaesth 1995;75:752-5
16. Williams JP, Thompson JP, McDonald J, et al. Human peripheral blood mononuclear cells express nociceptin/orphanin FQ, but not mu, delta, or kappa opioid receptors. Anesth Analg 2007;105:998-1005, table of contents
17. Williams JP, Thompson JP, Rowbotham DJ, Lambert DG. Human peripheral blood mononuclear cells produce pre-pro-nociceptin/orphanin FQ mRNA. Anesth Analg 2008;106:865-6, table of contents
18. Wittert G, Hope P, Pyle D. Tissue distribution of opioid receptor gene expression in the rat. Biochem Biophys Res Commun 1996;218:877-81
19. Duncan DJ, Hopkins PM, Harrison SM. Negative inotropic effects of tumour necrosis factor-alpha and interleukin-1beta are ameliorated by alfentanil in rat ventricular myocytes. Br J Pharmacol 2007;150:720-6
20. Hung CF, Tsai CH, Su MJ. Opioid receptor independent effects of morphine on membrane currents in single cardiac myocytes. Br J Anaesth 1998;81:925-31
21. Llobell F, Laorden ML. Characterization of the opioid receptor subtypes mediating the negative inotropic effects of DAMGO, DPDPE and U-50, 488H in isolated human right atria strips. Neuropeptides 1995;29:115-9
22. Balasubramanian S, Ramakrishnan S, Charboneau R, Wang J, Barke RA, Roy S. Morphine sulfate inhibits hypoxia-induced vascular endothelial growth factor expression in endothelial cells and cardiac myocytes. J Mol Cell Cardiol 2001;33:2179-87
23. Head BP, Patel HH, Roth DM, et al. G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J Biol Chem 2005;280:31036-44
24. Rizzi A, Rizzi D, Marzola G, et al. Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice. Br J Pharmacol 2002;137:369-74
25. 2), a novel, functionally selective nociceptin/orphanin FQ peptide receptor partial agonist with sodium-potassium-sparing aquaretic activity. J Pharmacol Exp Ther 2005;314:652-60
26. Simonsen U, Laursen BE, Petersen JS. ZP120 causes relaxation by pre-junctional inhibition of noradrenergic neurotransmission in rat mesenteric resistance arteries. Br J Pharmacol 2008;153:1185-94
27. Fischetti C, Rizzi A, Gavioli EC, et al. Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120. Peptides 2009;30:248-55
28. Petersen J. ZP120-introduction of a new 'first-in-class' agent for the treatment of acute heart failure. European Opioid Colloquium Abstract. Salamanca Meeting. 2006
29. Williams JP, Lambert DG. Opioids and the neuroimmune axis. Br J Anaesth 2005;94:3-6
30. Fontana F, Bernardi P, Pizzi C, Spampinato S, Bedini A, Pich EM. Plasma nociceptin/orphanin FQ levels rise after spontaneous episodes of angina, but not during induced myocardial ischemia. Peptides 2009;30:1705-9
31. Granata F, Potenza RL, Fiori A, et al. Expression of OP4 (ORL1, NOP1) receptors in vascular endothelium. Eur J Pharmacol 2003;482:17-23
32. Dahan A, Kest B, Waxman AR, Sarton E. Sex-specific responses to opiates: animal and human studies. Anesth Analg 2008;107:83-95